| Patents for C07D 241 - Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings (18,673) |
|---|
| 02/06/2007 | US7173131 Anthryl derivative group substituted compound, and organic luminescent device making use of same |
| 02/06/2007 | US7173130 Detection of transmembrane potentials by optical methods |
| 02/06/2007 | US7173035 Arylsulfonamide compounds |
| 02/01/2007 | US20070027157 Quinoxalinone-3-one derivatives as orexin receptor antagonists |
| 02/01/2007 | US20070027147 Biarylurea derivatives |
| 01/31/2007 | EP1747196A2 Substituted aryl acylthioureas and related compounds; inhibitors of viral replication |
| 01/31/2007 | EP1746880A1 Quinoxalin-2-one derivatives crop protection agents comprising the same and method for production and use therof |
| 01/31/2007 | CN1906190A 选择性激酶抑制剂 Selective kinase inhibitor |
| 01/30/2007 | CA2228939C Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same |
| 01/25/2007 | WO2007010463A2 2-amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives |
| 01/25/2007 | WO2007009741A1 Piperazinone derivatives useful as histamine h3 receptor antagonists and/or inverse agonists |
| 01/25/2007 | WO2006050240A3 Heterocyclical anti-aromatic chromophore architectures |
| 01/25/2007 | US20070021606 Therapeutic compounds |
| 01/24/2007 | EP1746088A1 2-Amino-5-aminomethyl-phenol derivatives and agent for coloring keratin fibers comprising these derivatives |
| 01/24/2007 | EP1745042A1 Diarylamine derivatives as calcium channel blockers |
| 01/24/2007 | EP1745041A2 Quinoxaline inhibitors of the hedgehog signalling pathway |
| 01/24/2007 | EP1745019A1 Novel compounds of proline and morpholine derivatives |
| 01/24/2007 | EP0968206B8 N-heterocyclic derivatives as nos inhibitors |
| 01/24/2007 | CN1902193A Quinoxalines useful as inhibitors of protein kinases |
| 01/24/2007 | CN1902171A Benzylether amine compounds useful as CCR-5 antagonists |
| 01/24/2007 | CN1901971A Cyclopropane compounds and pharmaceutical use thereof |
| 01/24/2007 | CN1901917A (3-oxo-3, 4-dihydro-quinoxalin-2-yl-amino) -benzamide derivatives and related compound as glycogen phosphorylase inhibitors for the treatment of diabetes and obesity |
| 01/24/2007 | CN1296357C Heteroaryl-substituted aminocyclohexane derivatives |
| 01/24/2007 | CN1296346C Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical |
| 01/23/2007 | US7166745 Acyclic and macrocyclic, aliphatic diammonium surfactants for use in forming lipid aggregates for drug delivery of macromolecules; improved versatility among different cell types and broadened range of molecules to be carried |
| 01/23/2007 | US7166608 for use with various disorders including sleep disorders; depression; cardiovascular disorders; pain; neurodegenerative disorders; psychiatric disorders etc. |
| 01/23/2007 | US7166600 Resistant to metabolism, improved half-life and/or clearance properties compared to corresponding carbamates; e.g N-(2-chlorobenzoyl)-p-(morpholinothiocarbonyloxy)tyrosine; used to treat inflammatory diseases e.g rheumatoid arthritis, asthma, psoriasis, multiple sclerosis, inflammatory bowel disease |
| 01/23/2007 | US7166598 Piperazine derivatives |
| 01/23/2007 | US7166593 Glucocorticoid receptor modulators |
| 01/18/2007 | WO2007008963A1 Mao-b inhibitors useful for treating obesity |
| 01/18/2007 | WO2007007886A1 An oxime derivative and preparations thereof |
| 01/18/2007 | US20070015762 NPY Y5 antagonist |
| 01/18/2007 | US20070015734 Mao-b inhibitors useful for treating obesity |
| 01/17/2007 | EP1743632A1 Novel 4-dedimethy laminotetracycline derivatives |
| 01/17/2007 | EP1742927A1 Butanoic acid derivatives, processes for the preparation thereof, pharmaceutical compositions comprising them, and therapeutic applications threreof |
| 01/17/2007 | EP1742904A2 Substituted enaminones, their derivatives and uses thereof |
| 01/17/2007 | EP1401575B1 Hydroxylation of beta-dicarbonyls with zirconium catalysts |
| 01/17/2007 | EP1400518B1 Heterocyclic compound derivatives and medicines |
| 01/17/2007 | CN1898234A Substituted cyclic hydroxamates as inhibitors of matrix metalloproteinases |
| 01/17/2007 | CN1897928A Novel alanyl-amino peptidase inhibitors for functionally influencing different cells and treating immunological, inflammatory, neuronal, and other diseases |
| 01/11/2007 | WO2007005774A2 Novel derivatives of amino acids for treatment of obesity and related disorders |
| 01/11/2007 | WO2006118955A3 Process for preparing 3,3-disubstituted oxindoles and thio-oxindoles |
| 01/11/2007 | WO2006116007A3 Methods for synthesis of dicarbamate compounds and intermediates in the formation thereof |
| 01/11/2007 | US20070010520 Triazolopyrazines and methods of making and using the same |
| 01/11/2007 | CA2614116A1 Histamine h3 receptor antagonists |
| 01/10/2007 | EP1740575A2 Pyrrolidine derivatives useful as bace inhibitors |
| 01/10/2007 | EP1740573A1 Amides as bace inhibitors |
| 01/10/2007 | EP1740553A1 Aryl glycinamide derivatives and their use as nk1 antagonists and serotonin reuptake inhibithors |
| 01/10/2007 | EP1740552A1 2- ( arylalkoxy ) -1- phenylethylamine derivatives as nk1 antagonist and serotonin reuptake inhibitors |
| 01/10/2007 | CN1894227A Phenylpiperazine cycloalkanol derivatives and methods of their use |
| 01/10/2007 | CN1891701A Heteraromatic ring thiosemicarbazone compound, and its derivatives and their use forpreparing antitumour medicine |
| 01/09/2007 | US7160907 Pleuromutilin derivatives |
| 01/09/2007 | US7160887 Aromatic amine derivatives, their production and use |
| 01/09/2007 | CA2102780C Bis mono-and bicyclic aryl and heteroaryl compounds which inhibit egf and/or pdgf receptor tyrosine kinase |
| 01/04/2007 | WO2006039325A3 Aminopiperidines as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes |
| 01/04/2007 | WO2006004684A8 3-aminocyclopentanecarboxamides as modulators of chemokine receptors |
| 01/04/2007 | WO2005048922A3 Sulfonylaminovalerolactams and derivatives thereof as factor xa inhibitors |
| 01/04/2007 | US20070004750 such as 1-Benzyl-4-[(3,5-dimethylisoxazol-4-yl)carbonyl]piperazine, used for controlling fungi and insects; insecticides; fungicides |
| 01/04/2007 | US20070004743 Intranasal administration of mc4-r agonists |
| 01/04/2007 | US20070004742 Arylpiperazinyl compounds |
| 01/04/2007 | US20070004725 Novel derivatives of amino acids for treatment of obesity and related disorders |
| 01/03/2007 | EP1737826A1 Alpha-4 integrin mediated cell adhesion inhibitors for the treatment or prevention of inflammatory diseases |
| 01/03/2007 | EP1423381B1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases |
| 01/03/2007 | CN1890240A Diazabicyclononene derivatives and their use as renin inhibitors |
| 01/03/2007 | CN1890225A Substituted 6-cyclohexylalkyl substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose) polymerase inhibitors |
| 01/03/2007 | CN1890224A 6-substituted 2-quinolinones and 2-quinoxalinones as poly(ADP-ribose)polymerase inhibitors |
| 01/03/2007 | CN1890218A Tubulin inhibitors |
| 01/02/2007 | US7157585 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent and for use in the treatment of mast cell mediated diseases such as asthma and other allergic and inflammatory conditions |
| 01/02/2007 | CA2373999C Pyrazinone thrombin inhibitors |
| 01/02/2007 | CA2274464C Ketobenzamides as calpain inhibitors |
| 12/28/2006 | WO2006050054A3 Compounds and methods of use thereof |
| 12/28/2006 | US20060293333 Therapeutic amides |
| 12/28/2006 | US20060293332 Sulfonylquinoxalone derivatives and related compounds as bradykinin antagonists |
| 12/27/2006 | EP1736468A2 Isatin derivatives with neurotrophic activity useful in the treatment of diseases mediated by the nerve growth factor (NGF) activation |
| 12/27/2006 | EP1735288A1 Isoxazole- and isothiazole-amine compounds for the treatment of neurodegenerative disorders |
| 12/27/2006 | EP1735280A1 Aryl sulfonamide and sulfonyl compounds as modulators of ppar and methods of treating metabolic disorders |
| 12/27/2006 | EP1735268A1 Opioid receptor antagonists |
| 12/27/2006 | EP1734942A1 Substituted urea and carbamate, phenacyl-2-hydroxy-3-diaminoalkane, and benzamide-2-hydroxy-3-diaminoalkane aspartyl-protease inhibitors |
| 12/27/2006 | EP1654324B1 Sulphonamide anions as catalysts for nco oligomerisation |
| 12/27/2006 | EP1021410B1 Prostaglandin agonists and their use to treat bone disorders |
| 12/27/2006 | CN1886843A Electroluminescent devices comprising 2-(p-triphenyl)-3-phenyl-pyrazine derivatives |
| 12/27/2006 | CN1886421A Hemiasterlin derivatives and uses thereof |
| 12/27/2006 | CN1886389A 喹喔啉化合物 Quinoxaline compounds |
| 12/27/2006 | CN1291983C Luminescent element material and luminescent element comprising the same |
| 12/26/2006 | US7154002 Phenylglycinamide derivatives containing a substituent capable of complexing with a protein metal ion, particularly an acrylhydroxamic group, e.g., 3-(3-{Benzylcarbamoyl-[formyl-(4-phenoxy-phenyl)-amino]-methyl}-phenyl)-N-hydroxy-acrylamide; antiproliferative agents |
| 12/26/2006 | US7153965 Pharmaceutically acceptable inorganic and organic salts of 5-methylpyrazine-2-carboxylic acid-4-oxide |
| 12/26/2006 | US7153889 Alzheimer's disease; antihistamines; attention deficit disorders; hyperactivity; bipolar disorders; cognition activators; psychological disorders; anticancer agents; antidepressants; antiepileptic agents; gastrointestinal disorders ; analgesics |
| 12/26/2006 | US7153876 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use |
| 12/26/2006 | US7153859 For prophylaxis and therapy of asthma, chronic obstructive pulmonary disease, chronic bronchitis, atopic dermatitis, urticaria, allergic rhinitis, allergic conjunctivitis, vernal conjunctivitis, eosinophilia, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis, Crohn's disease |
| 12/26/2006 | US7153857 antiinflammatory agents; antiarthritic agents; anticancer agents |
| 12/26/2006 | US7153856 Orally administering N-(2-chloro-6-methylphenyl)-2-[4-(4-(2-hydroxyethyl)piperazin-1-yl)-2-methylpyrimidin-6-ylamino]thiazole-5-carboxamide for treating cancer |
| 12/26/2006 | US7153815 Insecticide containing hydrazone derivative as the active ingredient and novel hydrazone derivative |
| 12/21/2006 | WO2006133784A1 Use of substituted piperazine derivatives and morpholine derivatives |
| 12/21/2006 | US20060287525 For post-chemotherapy or post-operative surgery nausea and vomitting; sustained release |
| 12/21/2006 | US20060287338 Metalloproteinase inhibitor compounds |
| 12/21/2006 | US20060287332 Melanocortin Receptor-Specific Piperazine and Keto-Piperazine Compounds |
| 12/21/2006 | US20060287331 Melanocortin receptor-specific piperazine compounds with diamine groups |
| 12/21/2006 | US20060287327 androgen-dependent diseases, such as prostate cancer, benign prostatic hyperplasia, polycystic ovarian syndrome, acne, hirsutism, seborrhea, androgenic alopecia and male baldness; LHRH (luteinizing hormone-releasing hormone) modulator |
| 12/21/2006 | US20060287326 17-Acetamido-4-azasteroid derivatives as androgen receptor modulators |
| 12/21/2006 | US20060287293 1-(4-{ethyl-[2-(4-methanesulfonylphenyl)-1-methylethyl]amino}butyl)-4-methanesulfonyl-[1,4]diazepan-2-one; repiratory system disorders: asthma and chronic obstructive pulmonary disease; nervous system, muscular,urogenital, gastrointestinal disorders; antiallergens; side effect reduction |